Dieter, S. M., Heining, C., Agaimy, A., Huebschmann, D., Bonekamp, D., Hutter, B., Ehrenberg, K. R., Fröhlich, M., Schlesner, M., Scholl, C., Schlemmer, H., Wolf, S., Mavratzas, A., Jung, C. S., Gröschel, S., von Kalle, C., Eils, R., Brors, B., Penzel, R., Kriegsmann, M., Reuss, D. E., Schirmacher, P., Stenzinger, A., Federspil, P. A., Weichert, W., Glimm, H., & Fröhling, S. (2017). mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. Annals of oncology, 28, 142–148. http://access.bl.uk/ark:/81055/vdc_100126095287.0x000030